Event dossier

Weight-loss drugs may lower the risk of depression, anxiety, and self-harm, study finds

GLP-1 weight-loss drugs with semaglutide were associated with a lower risk of depression, anxiety, substance use disorders, and self-harm, according to a new study.

1 report1 sourceMar 19, 2026, 7:00 AM
FilterEuronews
Clustered coverageEuronews
Coverage timeline1
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

EuronewsMar 19, 2026, 7:00 AM

Weight-loss drugs may lower the risk of depression, anxiety, and self-harm, study finds

GLP-1 weight-loss drugs with semaglutide were associated with a lower risk of depression, anxiety, substance use disorders, and self-harm, according to a new study.

Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.

El Psy Congroo Newswire